TITLE:
Study to Assess the Efficacy and Safety of Rituximab in Patients With Rheumatoid Arthritis

CONDITION:
Rheumatoid Arthritis

INTERVENTION:
methotrexate

SUMMARY:

      This study will assess the efficacy and safety of different treatment regimens of rituximab
      (MabThera/Rituxan), corticosteroids, and placebo, combined with methotrexate (MTX), in
      patients with active rheumatoid arthritis (RA).
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        Eligibility criteria include, but are not limited to the following:

          -  Are between the ages of 18 and 80 years.

          -  Have been diagnosed with rheumatoid arthritis for at least 6 months.

          -  Have failed treatment (lack of efficacy) with at least 1 but no more than 5
             disease-modifying anti-rheumatic drugs or biologics (other than methotrexate).
      
